Browse by Journal Title

2024

Incidence of Parkinson’s disease in Germany based on prevalence data from 70 million patients of the statutory health insurance.
Wattenbach, C., Ellrichmann, G., Feinkohl, I., Voß, S. and Brinks, R.
BMC Neurology 24 (1): 221. 27 June 2024

Childhood and adolescence factors and multiple sclerosis: results from the German National Cohort (NAKO).
Holz, A., Obi, N., Ahrens, W., Berger, K., Bohn, B., Brenner, H., Fischer, B., Fricke, J., Führer, A., Gastell, S., Greiser, K.H., Harth, V., Heise, J.K., Holleczek, B., Keil, T., Klett-Tammen, C.J., Leitzmann, M., Lieb, W., Meinke-Franze, C., Michels, K.B., Mikolajczyk, R., Nimptsch, K., Peters, A., Pischon, T., Riedel, O., Schikowski, T., Schipf, S., Schmidt, B., Schulze, M.B., Stang, A., Hellwig, K., Riemann-Lorenz, K., Heesen, C. and Becher, H.
BMC Neurology 24 : 123. 13 April 2024

2022

Berlin Registry of Neuroimmunological entities (BERLimmun): protocol of a prospective observational study.
Sperber, P.S., Brandt, A.U., Zimmermann, H.G., Bahr, L.S., Chien, C., Rekers, S., Mähler, A., Böttcher, C., Asseyer, S., Duchow, A.S., Bellmann-Strobl, J., Ruprecht, K., Paul, F. and Schmitz-Hübsch, T.
BMC Neurology 22 (1): 479. 14 December 2022

2020

Fingolimod after a first unilateral episode of acute optic neuritis (MOVING) - preliminary results from a randomized, rater-blind, active-controlled, phase 2 trial.
Albert, C., Mikolajczak, J., Liekfeld, A., Piper, S.K., Scheel, M., Zimmermann, H.G., Nowak, C., Dörr, J., Bellmann-Strobl, J., Chien, C., Brandt, A.U., Paul, F. and Hoffmann, O.
BMC Neurology 20 (1): 75. 3 March 2020

2019

Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy.
Klehmet, J., Beutner, S., Hoffmann, S., Dornauer, M., Paul, F., Reilmann, R., Brandt, A.U. and Meisel, A.
BMC Neurology 19 (1): 118. 8 June 2019

2017

Electrocardiographic assessments and cardiac events after fingolimod first dose - a comprehensive monitoring study.
Limmroth, V., Ziemssen, T., Lang, M., Richter, S., Wagner, B., Haas, J., Schmidt, S., Gerbershagen, K., Lassek, C., Klotz, L., Hoffmann, O., Albert, C., Schuh, K., Baier-Ebert, M., Wendt, G., Schieb, H., Hoyer, S., Dechend, R. and Haverkamp, W.
BMC Neurology 17 (1): 11. 18 January 2017

Subjective and objective assessment of physical activity in multiple sclerosis and their relation to health-related quality of life.
Krüger, T., Behrens, J.R., Grobelny, A., Otte, K., Mansow-Model, S., Kayser, B., Bellmann-Strobl, J., Brandt, A.U., Paul, F. and Schmitz-Hübsch, T.
BMC Neurology 17 (1): 10. 13 January 2017

2015

Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot study.
Hoffmann, S., Siedler, J., Brandt, A.U., Piper, S.K., Kohler, S., Sass, C., Paul, F., Reilmann, R. and Meisel, A.
BMC Neurology 15 (1): 265. 23 December 2015

2014

Relations of low contrast visual acuity, quality of life and multiple sclerosis functional composite: a cross-sectional analysis.
Schinzel, J., Zimmermann, H., Paul, F., Ruprecht, K., Hahn, K., Brandt, A.U. and Dörr, J.
BMC Neurology 14 : 31. 20 February 2014

2013

Low contrast visual acuity testing is associated with cognitive performance in multiple sclerosis: a cross-sectional pilot study.
Wieder, L., Gäde, G., Pech, L.M., Zimmermann, H., Wernecke, K.D., Dörr, J.M., Bellmann-Strobl, J., Paul, F. and Brandt, A.U.
BMC Neurology 13 : 167. 8 November 2013

2011

Environmental factors in early childhood are associated with multiple sclerosis: a case-control study.
Conradi, S., Malzahn, U., Schroeter, F., Paul, F., Quill, S., Spruth, E., Harms, L., Then Bergh, F., Ditzenbach, A., Georgi, T., Heuschmann, P. and Rosche, B.
BMC Neurology 11 : 123. 6 October 2011